ArticleCancers2022

Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribute to Gemcitabine Resistance in Pancreatic Cancer.

Hai Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.